|Comparing COVID-19 vaccines for their characteristics, efficacy and effectiveness against SARS-CoV-2 and variants of concern: a narrative review|
T Fiolet, Y Kherabi, CJ MacDonald, J Ghosn, N Peiffer-Smadja
Clinical Microbiology and Infection 28 (2), 202-221, 2022
|Type 1 interferons as a potential treatment against COVID-19|
E Sallard, FX Lescure, Y Yazdanpanah, F Mentre, N Peiffer-Smadja
Antiviral research 178, 104791, 2020
|Autoantibodies neutralizing type I IFNs are present in~ 4% of uninfected individuals over 70 years old and account for~ 20% of COVID-19 deaths|
P Bastard, A Gervais, T Le Voyer, J Rosain, Q Philippot, J Manry, ...
Science immunology 6 (62), eabl4340, 2021
|Remdesivir plus standard of care versus standard of care alone for the treatment of patients admitted to hospital with COVID-19 (DisCoVeRy): a phase 3, randomised, controlled …|
F Ader, M Bouscambert-Duchamp, M Hites, N Peiffer-Smadja, J Poissy, ...
The Lancet Infectious Diseases 22 (2), 209-221, 2022
|X-linked recessive TLR7 deficiency in~ 1% of men under 60 years old with life-threatening COVID-19|
T Asano, B Boisson, F Onodi, D Matuozzo, M Moncada-Velez, ...
Science immunology 6 (62), eabl4348, 2021
|Effect of hydroxychloroquine with or without azithromycin on the mortality of coronavirus disease 2019 (COVID-19) patients: a systematic review and meta-analysis|
T Fiolet, A Guihur, ME Rebeaud, M Mulot, N Peiffer-Smadja, ...
Clinical microbiology and infection 27 (1), 19-27, 2021
|Machine learning for clinical decision support in infectious diseases: a narrative review of current applications|
N Peiffer-Smadja, TM Rawson, R Ahmad, A Buchard, P Georgiou, ...
Clinical Microbiology and Infection 26 (5), 584-595, 2020
|Neurological manifestations associated with SARS-CoV-2 and other coronaviruses: A narrative review for clinicians|
A Maury, A Lyoubi, N Peiffer-Smadja, T De Broucker, E Meppiel
Revue neurologique 177 (1-2), 51-64, 2021
|Open science saves lives: lessons from the COVID-19 pandemic|
L Besançon, N Peiffer-Smadja, C Segalas, H Jiang, P Masuzzo, C Smout, ...
BMC Medical Research Methodology 21 (1), 1-18, 2021
|Neurologic manifestations associated with COVID-19: a multicentre registry|
E Meppiel, N Peiffer-Smadja, A Maury, I Bekri, C Delorme, V Desestret, ...
Clinical Microbiology and Infection 27 (3), 458-466, 2021
|Diabetes, hypertension, body mass index, smoking and COVID-19-related mortality: a systematic review and meta-analysis of observational studies|
Y Mahamat-Saleh, T Fiolet, ME Rebeaud, M Mulot, A Guihur, D El Fatouhi, ...
BMJ open 11 (10), e052777, 2021
|Challenges and issues about organizing a hospital to respond to the COVID-19 outbreak: experience from a French reference centre|
N Peiffer-Smadja, JC Lucet, G Bendjelloul, L Bouadma, S Gerard, ...
Clinical Microbiology and Infection 26 (6), 669-672, 2020
|Clinical characteristics of ambulatory and hospitalized patients with monkeypox virus infection: an observational cohort study|
M Mailhe, AL Beaumont, M Thy, D Le Pluart, S Perrineau, ...
Clinical Microbiology and Infection 29 (2), 233-239, 2023
|Omicron SARS-CoV-2 variant: What we know and what we don’t|
VM Ferré, N Peiffer-Smadja, B Visseaux, D Descamps, J Ghosn, ...
Anaesthesia, critical care & pain medicine 41 (1), 100998, 2022
|Review of trials currently testing treatment and prevention of COVID-19|
PC Fragkou, D Belhadi, N Peiffer-Smadja, CD Moschopoulos, FX Lescure, ...
Clinical Microbiology and Infection 26 (8), 988-998, 2020
|The risk of COVID-19 death is much greater and age dependent with type I IFN autoantibodies|
J Manry, P Bastard, A Gervais, T Le Voyer, J Rosain, Q Philippot, ...
Proceedings of the National Academy of Sciences 119 (21), 2022
|Assessment of air contamination by SARS-CoV-2 in hospital settings|
G Birgand, N Peiffer-Smadja, S Fournier, S Kerneis, FX Lescure, JC Lucet
JAMA network open 3 (12), e2033232-e2033232, 2020
|An open-label randomized controlled trial of the effect of lopinavir/ritonavir, lopinavir/ritonavir plus IFN-β-1a and hydroxychloroquine in hospitalized patients with COVID-19|
F Ader, N Peiffer-Smadja, J Poissy, M Bouscambert-Duchamp, D Belhadi, ...
Clinical microbiology and infection 27 (12), 1826-1837, 2021
|Effect of hydroxychloroquine with or without azithromycin on the mortality of COVID-19 patients: a systematic review and meta-analysis|
T Fiolet, A Guihur, M Rebeaud, M Mulot, N Peiffer-Smadja, ...
Clin Microbiol Infect 27, 19-27, 2020
|Performance and impact of a multiplex PCR in ICU patients with ventilator-associated pneumonia or ventilated hospital-acquired pneumonia|
N Peiffer-Smadja, L Bouadma, V Mathy, K Allouche, J Patrier, M Reboul, ...
Critical care 24, 1-10, 2020